{
    "id": 3288,
    "fullName": "EGFR L858M",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EGFR L858M lies within the protein kinase domain of the Egfr protein (UniProt.org). L858M is enriched in growth factor-independent cells in a high-throughput screening assay (PMID: 30952700), but has not been biochemically characterized and therefore, its effect on Egfr protein function is unknown.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 15530,
                    "pubMedId": 30952700,
                    "title": "An unbiased in vitro screen for activating epidermal growth factor receptor mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30952700"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "L858M",
    "createDate": "02/21/2015",
    "updateDate": "02/10/2020",
    "referenceTranscriptCoordinates": {
        "id": 135768,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55191821C>A",
        "cDna": "c.2572C>A",
        "protein": "p.L858M",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3328,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Gilotrif (afatinib) treatment resulted in partial response in 100% (2 of 2) of non-small cell lung carcinoma patients harboring EGFR L858M mutation (PMID: 26354527).",
            "molecularProfile": {
                "id": 3104,
                "profileName": "EGFR L858M"
            },
            "therapy": {
                "id": 623,
                "therapyName": "Afatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 3736,
                    "pubMedId": 26354527,
                    "title": "Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26354527"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3104,
            "profileName": "EGFR L858M",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135768,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55191821C>A",
            "cDna": "c.2572C>A",
            "protein": "p.L858M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}